The blood ketone meter market is poised for robust growth, with an estimated valuation of US$468 million in 2024 and an expected increase to US$750 million by 2031. This represents a CAGR of 7% from 2024 to 2031, driven by factors ranging from the increasing prevalence of diabetes to the growing awareness of the importance of ketone monitoring in ketogenic diets. With significant technological...